iSpecimen Inc. - Common Stock (ISPC)

Frequently Asked Questions About iSpecimen Inc. - Common Stock (ISPC)

How can I invest in iSpecimen Inc.?

Investors can buy shares of iSpecimen Inc. through stock brokerage accounts, as the company is publicly traded on Nasdaq under the ticker ISPC. Potential investors should conduct thorough research and consider seeking advice from financial professionals before making investment decisions.

How does iSpecimen Inc. ensure the quality of its biospecimens?

iSpecimen Inc. implements stringent quality control measures throughout the biospecimen collection and processing processes. This includes adhering to ethical guidelines, maintaining chain-of-custody protocols, and collaborating with accredited labs to ensure that samples meet rigorous quality standards.

How does iSpecimen Inc. promote ethical practices in biospecimen collection?

Ethical practices are central to iSpecimen Inc.'s operations. The company ensures that all biospecimens are collected with informed consent from donors, and it adheres to strict regulatory requirements to protect donor privacy and ensure ethical sourcing.

How does iSpecimen Inc. source its biospecimens?

iSpecimen Inc. sources its biospecimens through partnerships with hospitals, clinics, and biobanks. By collaborating with healthcare institutions, the company ensures a diverse and representative collection of samples that meet the needs of various research projects.

How has iSpecimen Inc. performed financially in recent years?

iSpecimen Inc. has shown consistent revenue growth in recent years as it expands its customer base and enhances its biospecimen offerings. Regular financial disclosures indicate an upward trend in earnings, demonstrating a strong demand for its services within the biopharmaceutical sector.

Is iSpecimen Inc. publicly traded?

Yes, iSpecimen Inc. is publicly traded on the Nasdaq stock exchange under the ticker symbol ISPC. The company's public listing enables it to raise capital to fund its growth and broaden its service offerings in the biospecimen space.

What are the growth prospects for iSpecimen Inc.?

The growth prospects for iSpecimen Inc. appear promising as the demand for biospecimens continues to rise, driven by advancements in biomedical research and personalized medicine. The company aims to expand its service offerings and client base, positioning itself well within the evolving healthcare landscape.

What certifications or accreditations does iSpecimen Inc. have?

iSpecimen Inc. holds various certifications and accreditations that reflect its commitment to quality and compliance in biospecimen handling, such as HIPAA compliance for patient data privacy and ISO certifications for operational quality standards.

What does iSpecimen Inc. do?

iSpecimen Inc. is a company that facilitates the collection, storage, and distribution of human biospecimens for research and development purposes. By connecting researchers with a range of biological samples, the company supports advancements in personalized medicine, drug development, and clinical trials.

What initiatives does iSpecimen Inc. have in regard to sustainability?

iSpecimen Inc. is committed to sustainability by ensuring that its operations minimize waste and maximize resource efficiency. The company also considers environmental impacts during biospecimen collection and processing to contribute positively to healthcare and research without harming the environment.

What is iSpecimen Inc.'s business model?

iSpecimen Inc. operates on a B2B business model by connecting researchers with biospecimens needed for their studies. Its revenue primarily comes from fees associated with sample procurement, processing, and data management services offered to clients in the life sciences industry.

What is the mission of iSpecimen Inc.?

The mission of iSpecimen Inc. is to enable advancements in healthcare by providing researchers with high-quality biospecimens that are essential for understanding diseases, developing new treatments, and improving patient outcomes. The company aims to make biological samples more accessible for scientific research.

What partnerships does iSpecimen Inc. have?

iSpecimen Inc. has established partnerships with various academic institutions, hospitals, and pharmaceutical companies to enhance its biospecimen offerings and facilitate research. These partnerships are critical for expanding its sample inventory and improving accessibility for researchers.

What role does technology play in iSpecimen Inc.'s operations?

Technology plays an integral role in iSpecimen Inc.'s operations, particularly through its online platform that connects researchers with available biospecimens. This technology streamlines the ordering process, enhances data management, and provides traces of samples, facilitating efficient and transparent transactions.

What sectors does iSpecimen Inc. serve?

iSpecimen Inc. serves various sectors within the life sciences industry, including pharmaceutical companies, biotechnology firms, and academic research institutions. The company's services are crucial for drug discovery, clinical trials, and epidemiological studies.

What types of biospecimens does iSpecimen Inc. provide?

iSpecimen Inc. offers a wide range of biospecimens, including blood, tissue, saliva, and urine samples, collected from various patient populations. This variety allows researchers to conduct a diverse array of studies in fields such as oncology, immunology, and infectious diseases.

When was iSpecimen Inc. founded?

iSpecimen Inc. was founded in 2010. Since its inception, the company has focused on providing researchers with high-quality biospecimens and has steadily grown its operations to become a key player in the biobanking industry.

Where is iSpecimen Inc. located?

iSpecimen Inc. is headquartered in Lexington, Massachusetts. This location places the company in a vibrant biotech hub, enabling it to collaborate with numerous research institutions and pharmaceutical companies in the New England area.

Who are the key executives at iSpecimen Inc.?

iSpecimen Inc. is led by a team of experienced executives, including Chief Executive Officer Dr. David T. Evans, and Chief Financial Officer Mr. Mark B. Tempesta. Their combined expertise in biotechnology, business development, and finance drives the company's strategic initiatives.

What is the current price of iSpecimen Inc. - Common Stock?

The current price of iSpecimen Inc. - Common Stock is 1.130

When was iSpecimen Inc. - Common Stock last traded?

The last trade of iSpecimen Inc. - Common Stock was at 4:00 pm EDT on April 3rd, 2025